Patient-reported outcome measures (PROMs) have become an important tool for understanding the adverse effects of radical prostate cancer treatment and have been widely integrated into clinical practice. In this Review, the authors discuss the available PROMs for use in prostate cancer care and consider how data collection, interpretation, standardization and reporting will be crucial for the continued implementation of PROM instruments in prostate cancer pathways.
- Udit Singhal
- Ted A. Skolarus
- Daniela A. Wittmann
